Medications for Vasomotor Rhinitis

59 results

  • abigale

    (estradiol and norethindrone acetate)
    Xiromed LLC
    Abigale and Abigale Lo are indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as the prevention of postmenopausal osteoporosis, particularly in women at significant risk. Topical products and non-estrogen medications should be considered first for certain indications.

  • azelastine

    (Azelastine)
    Ascend Laboratories, LLC
    Azelastine HCl Nasal Spray is indicated for treating symptoms of seasonal allergic rhinitis in adults and children 5 years and older, as well as vasomotor rhinitis symptoms in adults and adolescents aged 12 years and older.

  • azelastine hydrochloride

    (AZELASTINE HYDROCHLORIDE)
    Breckenridge Pharmaceutical, Inc.
    Azelastine Hydrochloride Nasal Spray is indicated for treating seasonal allergic rhinitis symptoms in adults and children aged 5 and older, and vasomotor rhinitis symptoms in adults and adolescents aged 12 and older.

  • azelastine hydrochloride

    (AZELASTINE HYDROCHLORIDE)
    Aurobindo Pharma Limited
    Azelastine hydrochloride Nasal Spray is indicated for treating seasonal allergic rhinitis in adults and children aged 5 and older, as well as vasomotor rhinitis in adults and adolescents aged 12 and older.

  • azelastine hydrochloride

    (AZELASTINE HYDROCHLORIDE)
    H.J. Harkins Company Inc
    Azelastine Hydrochloride Nasal Spray is used to treat seasonal allergic rhinitis in adults and children (5+ years) and vasomotor rhinitis in adults and adolescents (12+ years).

  • azelastine hydrochloride

    (AZELASTINE HYDROCHLORIDE)
    RPK Pharmaceuticals, Inc.
    Azelastine hydrochloride Nasal Spray is indicated for treating symptoms of seasonal allergic rhinitis in adults and children aged 5 and older, and for vasomotor rhinitis symptoms in adults and adolescents aged 12 and older.

  • brisdelle

    (paroxetine)
    Legacy Pharma USA, Inc.
    BRISDELLE is indicated for treating moderate to severe vasomotor symptoms associated with menopause. It is not approved for psychiatric conditions, and its lower dosage for menopause is not established for any psychiatric use. Patients needing paroxetine for psychiatric issues should switch to a suitable paroxetine product.

  • carbinoxamine maleate

    (CARBINOXAMINE MALEATE)
    Foxland Pharmaceuticals, Inc.
    Carbinoxamine maleate is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, dermatographism, and as an adjunct therapy for anaphylactic reactions after acute symptoms have been controlled. It also helps reduce allergic reaction severity to blood or plasma.

  • climara

    (Estradiol)
    Bayer HealthCare Pharmaceuticals Inc.
    This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.

  • combipatch

    (estradiol/norethindrone acetate transdermal system)
    Noven Therapeutics, LLC
    CombiPatch is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause in women with a uterus, as well as for hypoestrogenism resulting from hypogonadism, castration, or primary ovarian failure.